top of page
Sanaz Attarha, PhD
Dr. Attarha joined the Page Lab in 2018 and has hit the ground running. Driving the development of new assays to look at cancer cell signaling, Sanaz' work aims to develop new assays and tools to decipher the molecular mechanisms of commonly used anti-cancer agents. With a better understanding of how these agents work, we aim to improve on these inhibitors to make more potent and safer drug analogues.
2018 - Current
Postdoctoral Fellow, Page Lab
Karolinska Institute, Stockholm, Sweden
Oncology and Pathology
RESEARCH INTERESTS
POSITIONS
Chemical Biology and Biotechnology
Target Enagement Assays
Drug-target Interactions
Cancer Biology and Signal Transduction
bottom of page